Skip to main content
KAPA logo

KAPA · Kairos Pharma, LTD.

Track KAPA — free
$1.61
Market Cap
$5.62M
Shares
3.39M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1962011 CUSIP 48301N104 13F (30d) 14 filings 14 filers Visit website Investor relations